| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-13 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-09 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-09 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |